Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
D000654:Amobarbital / Q000494:pharmacology*; D014150:Antipsychotic Agents; D001480:Basal Ganglia Diseases; D003131:Combined Modality Therapy; D004194:Disease; D005116:Extrapyramidal Tracts; D006801:Humans; D012559:Schizophrenia / Q000628:therapy*; D014149:Tranquilizing Agents / Q000633:toxicity*; D014268:Trifluoperazine
D014150:Antipsychotic Agents; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D000654:Amobarbital
AMOBARBITAL/pharmacology; EXTRAPYRAMIDAL TRACTS/diseases; SCHIZOPHRENIA/therapy; TRANQUILIZING AGENTS/toxicology